Page last updated: 2024-08-21

tartrazine and Experimental Mammary Neoplasms

tartrazine has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Awounfack, FC; Kada, MM; Kalgonbe, AY; Mindang, ELN; Ndinteh, DT; Njamen, D; Zingue, S	1

Other Studies

1 other study(ies) available for tartrazine and Experimental Mammary Neoplasms

Article	Year
Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats. BMC complementary medicine and therapies, 2021, Dec-31, Volume: 21, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; alpha-Fetoproteins; Animals; Biomarkers, Tumor; Carcinogens; Carcinoma; Estradiol; Female; Mammary Neoplasms, Experimental; Mucin-1; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Tartrazine; Tumor Burden	2021

Article

Year

Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats.

BMC complementary medicine and therapies, 2021, Dec-31, Volume: 21, Issue:1

Topics: 9,10-Dimethyl-1,2-benzanthracene; alpha-Fetoproteins; Animals; Biomarkers, Tumor; Carcinogens; Carcinoma; Estradiol; Female; Mammary Neoplasms, Experimental; Mucin-1; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Tartrazine; Tumor Burden

2021